Kathleen D. Albright

400 total citations
8 papers, 341 citations indexed

About

Kathleen D. Albright is a scholar working on Molecular Biology, Oncology and Computational Theory and Mathematics. According to data from OpenAlex, Kathleen D. Albright has authored 8 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Computational Theory and Mathematics. Recurrent topics in Kathleen D. Albright's work include Estrogen and related hormone effects (3 papers), Computational Drug Discovery Methods (3 papers) and Cancer therapeutics and mechanisms (2 papers). Kathleen D. Albright is often cited by papers focused on Estrogen and related hormone effects (3 papers), Computational Drug Discovery Methods (3 papers) and Cancer therapeutics and mechanisms (2 papers). Kathleen D. Albright collaborates with scholars based in United States. Kathleen D. Albright's co-authors include R D Christen, Jeffrey A. Jones, Stephen C. Mann, H. Huynh, Paul A. Andrews, Edward F. McClay, Stephen B. Howell, Alan Eastman, S B Howell and Gerrit Los and has published in prestigious journals such as Cancer, International Journal of Cancer and Cancer Chemotherapy and Pharmacology.

In The Last Decade

Kathleen D. Albright

8 papers receiving 334 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kathleen D. Albright United States 8 197 184 40 34 33 8 341
Doreen K. Hom United States 10 236 1.2× 205 1.1× 29 0.7× 26 0.8× 16 0.5× 15 371
Janet Ward United Kingdom 7 144 0.7× 197 1.1× 63 1.6× 35 1.0× 38 1.2× 8 419
Timothy Korbut United States 10 206 1.0× 183 1.0× 25 0.6× 23 0.7× 37 1.1× 16 396
Rosalind D. Friedman United States 9 221 1.1× 101 0.5× 20 0.5× 19 0.6× 75 2.3× 13 400
Kamil Wolyniec Australia 10 265 1.3× 205 1.1× 33 0.8× 31 0.9× 31 0.9× 12 472
Kerry A. Pickin United States 9 315 1.6× 187 1.0× 13 0.3× 19 0.6× 45 1.4× 11 456
Hongxie Shen United States 13 453 2.3× 135 0.7× 22 0.6× 13 0.4× 17 0.5× 14 543
K W Kohn United States 7 325 1.6× 234 1.3× 13 0.3× 60 1.8× 30 0.9× 9 465
Daniel M. López‐Larraza Argentina 10 248 1.3× 158 0.9× 18 0.5× 34 1.0× 33 1.0× 13 418
Emma S. Child United Kingdom 10 354 1.8× 235 1.3× 32 0.8× 31 0.9× 66 2.0× 16 560

Countries citing papers authored by Kathleen D. Albright

Since Specialization
Citations

This map shows the geographic impact of Kathleen D. Albright's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathleen D. Albright with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathleen D. Albright more than expected).

Fields of papers citing papers by Kathleen D. Albright

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathleen D. Albright. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathleen D. Albright. The network helps show where Kathleen D. Albright may publish in the future.

Co-authorship network of co-authors of Kathleen D. Albright

This figure shows the co-authorship network connecting the top 25 collaborators of Kathleen D. Albright. A scholar is included among the top collaborators of Kathleen D. Albright based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathleen D. Albright. Kathleen D. Albright is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Jones, Jeffrey A., et al.. (1997). Synergy between tamoxifen and cisplatin in human melanoma cells is dependent on the presence of antiestrogen-binding sites.. PubMed. 57(13). 2657–60. 17 indexed citations
2.
Jones, Jeffrey A., et al.. (1996). Determinants of tamoxifen sensitivity control the nature of the synergistic interaction between tamoxifen and cisplatin.. PubMed. 56(17). 3993–7. 15 indexed citations
3.
Nakata, Bunzo, et al.. (1995). Synergistic interaction between cisplatin and tamoxifen delays the emergence of cisplatin resistance in head and neck cancer cell lines. Cancer Chemotherapy and Pharmacology. 35(6). 511–518. 13 indexed citations
4.
McClay, Edward F., Kathleen D. Albright, Jeffrey A. Jones, R D Christen, & Stephen B. Howell. (1993). Tamoxifen modulation of cisplatin cytotoxicity in human malignancies. International Journal of Cancer. 55(6). 1018–1022. 31 indexed citations
5.
Albright, Kathleen D., et al.. (1993). Tamoxifen modulation of cisplatin resistance in patients with metastatic melanoma a biologically important observation. Cancer. 72(6). 1914–1918. 24 indexed citations
6.
Albright, Kathleen D., et al.. (1992). Mitochondrial defects in cis-diamminedichloroplatinum(II)-resistant human ovarian carcinoma cells.. PubMed. 52(7). 1895–901. 112 indexed citations
7.
McClay, Edward F., et al.. (1992). Modulation of cisplatin resistance in human malignant melanoma cells.. PubMed. 52(24). 6790–6. 54 indexed citations
8.
Andrews, Paul A., Stephen C. Mann, H. Huynh, & Kathleen D. Albright. (1991). Role of the Na+, K(+)-adenosine triphosphatase in the accumulation of cis-diamminedichloroplatinum(II) in human ovarian carcinoma cells.. PubMed. 51(14). 3677–81. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026